Ashton Thomas Private Wealth, LLC Gilead Sciences, Inc. Transaction History
Ashton Thomas Private Wealth, LLC
- $1.75 Trillion
- Q1 2024
A detailed history of Ashton Thomas Private Wealth, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 43,632 shares of GILD stock, worth $2.91 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
43,632
Previous 44,255
1.41%
Holding current value
$2.91 Million
Previous $3.59 Billion
10.85%
% of portfolio
0.18%
Previous 0.23%
Shares
13 transactions
Others Institutions Holding GILD
# of Institutions
1,885Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.17 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$7.65 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.64 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.08 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$3.85 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $83.6B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...